Janssen Neuroscience


Janssen Neuroscience is owned by Janssen Research & Development.

Johnson & Johnson is one of the...

Johnson & Johnson is a company listed under the stock ticker JNJ (US).

Johnson & Johnson has a direct presence in 25 countries.

Johnson & Johnson has 68 subsidiaries including Auris Health, Biosense Webster and DePuy Synthes.

They are in:

Acquisition, funding and merger involving Johnson & Johnson.


View the org chart displaying its 8 main executives

Most searched biographies at Janssen Neuroscience
Popular executive movements at Johnson & Johnson
  • Michael Sneed, Executive Vice President, Global Corporate Affairs and Chief Communication Officer, will retire on Apr. 1, 2022  (posted on December 10 2021)..
  • Vanessa Broadhurst who is Group Chairman, Global Commercial Strategy Organization , will be promoted to Executive Vice President, Global Corporate Affairs on Jan. 3, 2022  (posted on December 10 2021)..
  • Jessica Moore will join the company as Vice President of Investor Relations on Nov. 1, 2021  (posted on October 14 2021)..

Click here to view some more movements at Johnson & Johnson

Create an alert
to follow the executive moves at Janssen Neuroscience.


Johnson & Johnson has 2,036 competitors including Pfizer (United States (USA)), Roche (Switzerland) and Sanofi (France).

Popular M&A news in Pharmaceuticals
Popular contacts in Pharmaceuticals

Learn more about the Pharmaceuticals industry >


Press releases by Janssen Neuroscience
Social media about Janssen Neuroscience

The most constantly updated executive directory.



Learn about your clients' org charts. Understand their industries and their competitors.



View the executives' biographies. Contact the executives through our email platform.



Select key words to follow your clients. Receive alerts when executive movements happen.


Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.